Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Micron Technology Inc. €746.10 €1,291.8
Delta Air Lines Inc. €73.57 €72.95
Aerovironment €124.30 €257.49
Security Price Target price
Jetblue Airways Corp. €4.88 €3.44
Veganz Group AG €2.53 -
Factset Research Systems €225.50 €188.94

New Top predictions since last week

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

Krypto
Total
€53,115
Cash
€46.39
Performance (%)
-46.885%

Pros and Cons of these stocks (New Predictions)

UnitedHealth Group Inc.

WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Stock / Healthcare Providers & Services / Large Cap /

Pros
1
Revenue growth >5% per year expected
1
EBIT growth >5% per year expected
1
Higher EBIT margin than peer group
Cons
Coloplast A/S B

WKN: A1KAGC / Symbol: CLPBF / Name: Coloplast / Stock / Healthcare Equipment & Supplies / Large Cap /

Pros
3
Very Future proof/growth oriented business model
1
Known brand
2
Market Leader or Top 3
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Travelers Companies €322.60 8.870%
Seagate Technology.Holdings plc €690.00 6.440%
Western Union Co. €7.75 6.120%
Discovery Communications C €22.42 5.110%
Coty Inc €2.30 4.550%
Security Price Change(%) (%)
Intuitive Surgical Inc €301.80 -14.190%
Cadence Design Systems €288.55 -9.660%
Synopsys Inc. €336.00 -7.810%
Netflix Inc. €60.20 -6.850%
Newell Rubbermaid €4.58 -6.090%

Courses

Get started on the stock market in these easy steps
This course is directed at beginners who want to get started on the stock market.

Things you will learn:
  •  What is a stock
  •  What is a fund
  •  What is an ETF
  •  How to open a depot
  •  How to manage a depot that will regularly beat managed funds
  •  Why you mostly need patience to succeed on the stock market

sharewise Introduction:
sharewise Introduction
This is a course about the functionalities of sharewise. You will learn about the basics and how to best use the platform.

Predictions

buy
Ipg Photonics

Start price
Target price
Perf. (%)
€91.16
23:15
-
17.07.27
-
22:25

buy
ASML Holding N.V. ADR

Start price
Target price
Perf. (%)
€1,525.0
21:15
-
17.07.27
0.33%
22:25

buy
Deere Co.

Start price
Target price
Perf. (%)
€522.00
21:15
€598.83
17.07.27
0.00%
22:25

buy
Karo Pharma AB

Start price
Target price
Perf. (%)
€5.44
21:15
€65.57
17.07.27
-
24.11.22

Top News

News

Does T Stock Deserve a Spot in Your Portfolio Ahead of Q2 Earnings?
Does T Stock Deserve a Spot in Your Portfolio Ahead of Q2 Earnings?

AT&T Inc. T is scheduled to report second-quarter 2026 earnings on July 22, before the opening bell. The Zacks Consensus Estimate for revenues and earnings is pegged at $32.04 billion and 59 cents

QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway

uniQure N.V. QURE remains a catalyst-driven gene therapy stock, with AMT-130 shaping most of the investment debate. The program targets Huntington’s disease, an area where disease-modifying options

HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition
HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition

Harmony Biosciences HRMY announced preliminary second-quarter 2026 results.

The company registered a record $261 million in net product revenues from its lead drug, Wakix (pitolisant).

Wakix

Can Novartis' Fabhalta Strengthen Its Nephrology Franchise?
Can Novartis' Fabhalta Strengthen Its Nephrology Franchise?

Novartis NVS announced that the FDA has granted traditional approval to Fabhalta (iptacopan) for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) who are at

HONA Growth Trends Ride Aerospace Demand and Aftermarket Shift
HONA Growth Trends Ride Aerospace Demand and Aftermarket Shift

Honeywell Aerospace HONA has entered the market with exposure to several aerospace growth channels, from commercial aviation to defense and space. The stock’s long-term case depends on whether those

Reasons to Retain Doximity Stock in Your Portfolio for Now
Reasons to Retain Doximity Stock in Your Portfolio for Now

Doximity DOCS is entering a pivotal phase as it accelerates investments in artificial intelligence to expand beyond its core physician engagement platform. While robust physician adoption, growing

Is Honeywell Aerospace Stock Fairly Valued After Spinoff?
Is Honeywell Aerospace Stock Fairly Valued After Spinoff?

Honeywell Aerospace Inc. HONA enters the public market with scale, aerospace focus and a valuation that invites debate. The stock trades like a newly separated supplier with strong end-market

Honeywell Aerospace Stock Outlook After the Spin-Off Debut
Honeywell Aerospace Stock Outlook After the Spin-Off Debut

Honeywell Aerospace Inc. HONA entered the public market with a business investors can evaluate more directly: a scaled aerospace supplier tied to commercial aviation, business aviation, defense and

ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth

Intuitive Surgical, Inc. ISRG reported second-quarter 2026 adjusted earnings per share (EPS) of $2.80, which beat the Zacks Consensus Estimate of $2.48 by 12.9%. The bottom line increased 27.9% from

Contest

Compete in Catch the Monkey ...

... and win a prize!

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren